持續推進創新産品研發進程,遠大醫藥(00512)GPN00833國內III期臨床完成首例患者入組給藥,有望填補國內激素眼用制劑市場需求

Post Content

Read More 

You may also like...

Leave a Reply

Generated by Feedzy